Coe, L. | Search bioRxiv

bioRxiv2025

Optimizing cytochrome P450 activity for quillaic acid biosynthesis in Saccharomyces cerevisiae

QS-21, a saponin extract from the Chilean tree Quillaja saponaria, is gaining popularity as a potent vaccine adjuvant, but its production is constrained due to its low natural abundance and complex chemical structure of the triterpenoid saponins, which hinder large-scale production through plant extraction or chemical synthesis. Microbial biosynthesis presents a promising alternative, with Saccharomyces cerevisiae emerging as a desirable host for triterpenoid production. A key step toward microbial QS-21 synthesis is the efficient biosynthesis of its aglycone core, the triterpenoid quillaic acid. However, its efficient production remains limited by challenges of cytochrome P450 enzyme (CYP450s) activity, including cofactor availability and electron transfer efficiency. To address this limitation, we applied a multi-faceted metabolic engineering strategy to optimise CYP450 activity, including CYP450 expression and cytochrome P450 reductase (CPR) selection. Additionally, aligning CYP450 expression with the ethanol phase, enhanced the metabolic flux toward quillaic acid synthesis, leading to an 85-fold increase in titre. Together, these strategies led to a quillaic acid titre of 385 {+/-} 14 mg/L in flask fermentation. Fed-batch bioreactor fermentations increased quillaic acid titre to 471 {+/-} 20 mg/L and significantly increased the selectivity for QA from 32.6% to 65.1% of the total triterpenoids produced. These findings demonstrate the effectiveness of enhancing CYP450 activity through targeted strategies and reveal potential bottlenecks in CYP450 expression, providing valuable insights for future optimization of triterpenoid production in yeast.

synthetic biology↗

bioRxiv2022

Molecular mechanisms of microbiome modulation by the diatom secondary metabolite azelaic acid

Photosynthetic eukaryotes, such as microalgae and plants, foster fundamentally important relationships with their microbiome based on the reciprocal exchange of chemical currencies. Among these, the dicarboxylate metabolite azelaic acid (Aze) appears to play an important, but heterogeneous, role in modulating these microbiomes, as it is used as a carbon source for some heterotrophs but is toxic to others. However, the ability of Aze to promote or inhibit growth, as well as its uptake and assimilation mechanisms into bacterial cells are mostly unknown. Here, we use transcriptomics, transcriptional factor coexpression networks, uptake experiments, and metabolomics to unravel the uptake, catabolism and toxicity of Aze on two microalgal-associated bacteria, Phycobacter and Alteromonas, whose growth is promoted or inhibited by Aze, respectively. We identify the first putative Aze transporter in bacteria, a C4-TRAP transporter, and show that Aze is assimilated through fatty acid degradation, with further catabolism occurring through the glyoxylate and butanoate metabolism pathways when used as a carbon source. Phycobacter took up Aze at an initial uptake rate of 3.8x10-9 nmol cell-1 hr-1 and utilized it as a carbon source in concentrations ranging from 10 M-1 mM, suggesting a broad range of acclimation to Aze availability. For inhibited bacteria, we infer that Aze inhibits the ribosome and/or protein synthesis and that a suite of efflux pumps is utilized to shuttle Aze outside the cytoplasm. We demonstrate that seawater amended with Aze becomes enriched in bacterial families that can catabolise Aze, which appears to be a different mechanism from that in soil, where modulation by the host plant is required. This study enhances our understanding of carbon cycling in the oceans and how microscale chemical interactions can structure marine microbial populations. In addition, our findings unravel the role of a key chemical currency in the modulation of eukaryote-microbiome interactions across diverse ecosystems.

ecology↗